Galmed Pharmaceuticals logo

Galmed Pharmaceuticals Share Price Today (NASDAQ: GLMD)

Galmed Pharmaceuticals share price is $1.61 & ₹138.56 as on 15 Jun 2025, 2.30 'hrs' IST

$1.61

Market is closed - opens 7 PM, 16 Jun 2025

View live Galmed Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Galmed Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Galmed Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Galmed Pharmaceuticals share price movements

  • Today's Low: $1.54
    Today's High: $1.63

    Day's Volatility :5.83%

  • 52 Weeks Low: $1.15
    52 Weeks High: $23.80

    52 Weeks Volatility :95.17%

Galmed Pharmaceuticals (GLMD) Returns

PeriodGalmed Pharmaceuticals LtdIndex (Russel 2000)
3 Months
-36.0%
0.0%
6 Months
-51.07%
0.0%
1 Year
-58.42%
0.0%
3 Years
-98.07%
2.2%

Galmed Pharmaceuticals (GLMD) Key Statistics

in dollars & INR

Previous Close
$1.61
Open
$1.6
Today's High
$1.63
Today's Low
$1.535
Market Capitalization
$3.8M
Today's Volume
$300.2K
52 Week High
$23.8
52 Week Low
$1.15
Revenue TTM
$0.0
EBITDA
$-6.0M
Earnings Per Share (EPS)
$-6.84
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-49.58%

How to invest in Galmed Pharmaceuticals Stock (GLMD) from India?

It is very easy for Indian residents to invest directly in Galmed Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Galmed Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Galmed Pharmaceuticals or GLMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Galmed Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Galmed Pharmaceuticals shares which would translate to 0.535 fractional shares of Galmed Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Galmed Pharmaceuticals, in just a few clicks!

Returns in Galmed Pharmaceuticals (GLMD) for Indian investors in Rupees

The Galmed Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Galmed Pharmaceuticals investment value today

Current value as on today

₹44,857

Returns

₹55,143

(-55.14%)

Returns from Galmed Pharmaceuticals Stock

₹58,182 (-58.18%)

Dollar Returns*

₹3,039 (+3.04%)

Indian investors sentiment towards Galmed Pharmaceuticals (GLMD)

-63%

Period: May 15, 2025 to Jun 14, 2025. Change in 30 Days versus previous period

Search interest for Galmed Pharmaceuticals Stock from India on INDmoney has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Galmed Pharmaceuticals

  • Schonfeld Strategic Advisors LLC

    1.12%

  • Virtu Financial LLC

    0.49%

  • TWO SIGMA SECURITIES, LLC

    0.49%

  • Morgan Stanley - Brokerage Accounts

    0.33%

  • UBS Group AG

    0.30%

Analyst Recommendation on Galmed Pharmaceuticals

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Galmed Pharmaceuticals(by analysts ranked 0 to 5 stars)

Analyst Forecast on Galmed Pharmaceuticals Stock (GLMD)

What analysts predicted

Upside of 645.34%

Target:

$12.00

Current:

$1.61

Insights on Galmed Pharmaceuticals Stock (Ticker Symbol: GLMD)

  • Price Movement

    In the last 7 days, GLMD stock has moved up by 6.0%
  • GLMD vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 91.7% return, outperforming this stock by 151.6%
  • GLMD vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 127.0% return, outperforming this stock by 225.0%

Galmed Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Galmed Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Galmed Pharmaceuticals (GLMD) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Galmed Pharmaceuticals Ltd logo
34.45%
-51.07%
-58.42%
-98.07%
-99.82%
Regeneron Pharmaceuticals, Inc. logo
-11.02%
-27.05%
-49.42%
-5.02%
-10.81%
Beone Medicines Ltd logo
18.08%
52.93%
69.2%
101.57%
55.67%
Vertex Pharmaceuticals Incorporated logo
3.86%
-2.68%
-3.83%
81.53%
66.4%
Alnylam Pharmaceuticals, Inc. logo
7.76%
26.01%
95.45%
128.04%
132.45%

About Galmed Pharmaceuticals

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of Aramchol for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule for the treatment of non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study for HIV-associated lipodystrophy and non-alcoholic fatty liver disease. In addition, it develops products for cardiometabolic indications. The company has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with Virginia Commonwealth University to investigate the effect of adding Aramchol to prevent drug resistance to standard-of-care oncology agents in the treatment of hepatoma, cholangiocarcinoma, and colorectal cancer. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.
Organization
Galmed Pharmaceuticals
Employees
3
CEO
Mr. Allen Baharaff
Industry
Health Technology

Management People of Galmed Pharmaceuticals

NameTitle
Mr. Allen Baharaff
Co-Founder, President, CEO & Chairman
Mr. Doron Cohen
Chief Financial Officer
Mr. Guy Nehemya
COO & Data Protection Officer
Mr. Yohai Stenzler CPA
Chief Accounting Officer
Dr. Liat Hayardeny MBA, Ph.D.
Chief Scientific Officer
Dr. Tali Gorfine
Medical Consultant

Important FAQs about investing in GLMD Stock from India :

Can Indians buy Galmed Pharmaceuticals shares?

Yes, Indians can invest in the Galmed Pharmaceuticals (GLMD) from India.

With INDmoney, you can buy Galmed Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Galmed Pharmaceuticals at zero transaction cost.

How can I buy Galmed Pharmaceuticals shares from India?

It is very easy to buy Galmed Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Galmed Pharmaceuticals (GLMD) be purchased?

Yes, you can buy fractional shares of Galmed Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Galmed Pharmaceuticals stocks?

To start investing in Galmed Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Galmed Pharmaceuticals share price today?

Galmed Pharmaceuticals share price today stands at $1.61, Open: $1.60 ; Previous Close: $1.61 ; High: $1.63 ; Low: $1.54 ; 52 Week High: $23.80 ; 52 Week Low: $1.15.

The stock opens at $1.60, after a closing price of $1.61. The stock reached a daily high of $1.63 and a low of $1.54, with a 52-week high of $23.80 and a 52-week low of $1.15.

What are today’s High and Low prices of Galmed Pharmaceuticals Stock (GLMD)?

Today’s highest price of Galmed Pharmaceuticals (GLMD) is $1.63.

Today’s lowest price of Galmed Pharmaceuticals (GLMD) is $1.54.

What is the 52 Week High and Low Range of Galmed Pharmaceuticals Stock (GLMD)?

  • 52 Week High

    $23.80

  • 52 Week Low

    $1.15

What are the historical returns of Galmed Pharmaceuticals (GLMD)?

  • 1 Month Returns

    34.45%

  • 3 Months Returns

    -51.07%

  • 1 Year Returns

    -58.42%

  • 5 Years Returns

    -99.82%

What is today's market capitalisation of Galmed Pharmaceuticals?

Today's market capitalisation of Galmed Pharmaceuticals GLMD is 3.8M

Who is the Chief Executive Officer (CEO) of Galmed Pharmaceuticals ?

Mr. Allen Baharaff is the current Chief Executive Officer (CEO) of Galmed Pharmaceuticals.